Finance
Results: 27625-27636 of 50013

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance

Multiply Group Signs Landmark Investment with CVC and PAI Partners to Secure a Controlling Stake (67.91%) in Tendam, with the Transaction Expected to Double Multiply’s Operational EBITDA Post-Consolidation








